Business Wire

Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression

Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression Interim clinical trial data presented at American Vein and ...
Yahoo Finance

Koya Medical Announces TEAYS Full Study Results Show Dayspring's Superior Efficacy and Patient Satisfaction in the Treatment of Lower Extremity Lymphedema Compared to Advanced ...

OAKLAND, Calif., September 04, 2024--(BUSINESS WIRE)--Koya Medical, a healthcare company with a mission to transform venous and lymphatic treatments through novel, people-centric solutions, today ...
Business Wire

Koya Medical Secures First Reimbursement Codes for Dayspring, for Lymphedema; Publishes Clinical Data Demonstrating Improved Function, Appearance, Mood and Symptoms

OAKLAND, Calif.--(BUSINESS WIRE)--Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that its wearable, active ...
Yahoo Finance

Koya Medical Announces Two Clinical Data Publications for Dayspring® Active Compression Treatments for Lymphedema and Venous Disease

OAKLAND, Calif., October 04, 2022--(BUSINESS WIRE)--Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric ...
FOX40 News

Koya Medical Presents Two Newly Published Clinical Studies for Dayspring® Active Compression Treatments for Lymphedema and Venous Disease at the AVLS 2022 Annual Congress

OAKLAND, Calif., Oct. 24, 2022 /PRNewswire/ -- Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric ...
vator

Koya Medical raises $26M for its wearable lymphedema therapeutic

You may not have heard of lymphedema, but there’s a decent chance you know someone who has it: an estimated 20 million Americans live with the disease, which is chronic, progressive, and incurable ...
The Globe and Mail

Koya Medical Receives FDA Clearance for Dayspring Lite, Bringing Much-Needed Movement to People Beginning Compression Therapy to Treat Lymphedema and Venous Disease

Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, received Food and Drug Administration (FDA ...
Stockhouse

Koya Medical Receives FDA Clearance for Indication of First Mobility-Enabled Active Compression for Lower Extremities

OAKLAND, Calif. , May 26, 2021 /PRNewswire/ -- Koya Medical , a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that it has ...
Mena FN

Koya Medical Presents Two Newly Published Clinical Studies For Dayspring® Active Compression Treatments For Lymphedema And Venous Disease At The AVLS 2022 Annual Congress'

OAKLAND, Calif., Oct. 24, 2022 /PRNewswire/ -- Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric ...